["{\n\"step_by_step_thinking\": \"None of the provided documents relate to sacituzumab govitecan or breast cancer treatment options. The documents discuss multidrug resistance in breast cancer, the usefulness of steroid receptor data and breast patterns as a risk index for breast cancer, acid phosphatase (PAP) in prostate cancer, and adipose tissue's role in breast cancer etiology. Therefore, there is no relevant information to support or refute the effectiveness of sacituzumab govitecan for breast cancer.\",\n\"answer_choice\": \"B\"\n}"]